Search

Your search keyword '"diabesity"' showing total 368 results

Search Constraints

Start Over You searched for: Descriptor "diabesity" Remove constraint Descriptor: "diabesity"
368 results on '"diabesity"'

Search Results

1. Exploring diabesity pathophysiology through proteomic analysis using Caenorhabditis elegans.

2. Effect of interdisciplinary obesity care on metabolic markers and body weight in people with type 2 diabetes in a rural setting: A randomised controlled trial.

3. Bariatric and Metabolic Surgery for Diabesity: A Narrative Review.

4. Bariatric and Metabolic Surgery for Diabesity: A Narrative Review

5. Mechanisms of spinophilin-dependent pancreas dysregulation in obesity.

6. Assessment of the Liver Steatosis and Fibrosis Risk in Metabolic Syndrome and Its Individual Components, Considering the Varying Definitions Used in Clinical Practice throughout Time: A Retrospective Cross-Sectional Study.

7. Comprehensive Strategies for Metabolic Syndrome: How Nutrition, Dietary Polyphenols, Physical Activity, and Lifestyle Modifications Address Diabesity, Cardiovascular Diseases, and Neurodegenerative Conditions.

8. Exploring diabesity pathophysiology through proteomic analysis using Caenorhabditis elegans

9. Morus alba: natural and valuable effects in weight loss management

10. From classical dualistic antagonism to hormone synergy: potential of overlapping action of glucagon, insulin and GLP-1 for the treatment of diabesity

11. Advancements in the management of obesity: a review of current evidence and emerging therapies.

12. PREVALENCE OF DIABESITY IN ADULTS : A CROSS SECTIONAL STUDY IN RURAL FIELD PRACTICE AREA OF A TERTIARY HEALTH CARE CENTRE.

13. Long-term exposure to PM2.5 chemical constituents and diabesity: evidence from a multi-center cohort study in ChinaResearch in context

14. Metabolic surgery in patients with diabesity: A review of the historical backgrounds and scoring systems.

15. Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.

16. Diabesity phenotype in relation to the incidence and resolution of nonalcoholic fatty liver disease: A prospective cohort study.

17. Diabesity and Dietary Interventions: Evaluating the Impact of Mediterranean Diet and Other Types of Diets on Obesity and Type 2 Diabetes Management.

18. Gut microbiome as therapeutic target for diabesity management: opportunity for nanonutraceuticals and associated challenges.

19. Prevalence and Crucial Parameters in Diabesity-Related Liver Fibrosis: A Preliminary Study.

20. Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases.

21. Assessment of the Liver Steatosis and Fibrosis Risk in Metabolic Syndrome and Its Individual Components, Considering the Varying Definitions Used in Clinical Practice throughout Time: A Retrospective Cross-Sectional Study

22. Comprehensive Strategies for Metabolic Syndrome: How Nutrition, Dietary Polyphenols, Physical Activity, and Lifestyle Modifications Address Diabesity, Cardiovascular Diseases, and Neurodegenerative Conditions

23. Peel waste of citrus fruits: A valuable and renewable source of polyphenols for the treatment of diabesity

24. Diabetes and diabesity in the view of proteomics, drug, and plant-derived remedies.

25. The Correlation Between Health Risk Factors and Diabesity and Lipid Profile Indicators: The Role Mediator of TSH

26. Complex Association Among Diet Styles, Sleep Patterns, and Obesity in Patients with Diabetes

27. Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes.

28. Melatonin Improves Skeletal Muscle Structure and Oxidative Phenotype by Regulating Mitochondrial Dynamics and Autophagy in Zücker Diabetic Fatty Rat.

29. Diabesity: a superadded effect contributing to worse total primary hip replacement operative outcomes for patients with diabetes and obesity.

30. Pathya-Aahara-Vihaara for diabesity – A traditional approach to modern-day problem

31. Prevalence of and risk factors for diabesity in urban Chennai

32. Diabesity among the Yucatecan Maya: Metabolism, genotype, phenotype and considerations of the sociocultural environment and early development.

33. Designer GLP1 poly-agonist peptides in the management of diabesity.

34. Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options.

35. Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases

36. Synthesis, molecular docking, and pharmacological evaluation of 5-(4-(2-(5-ethyl pyridine-2-yl) ethoxy) benzyl)-3-(phenylsulfonyl) thiazolidine-2, 4-dione against HFD-induced diabesity via interaction with the CB1 receptor

37. Five blueberry anthocyanins and their antioxidant, hypoglycemic, and hypolipidemic effects in vitro

38. The relationship between sugar-sweetened beverages, sleep disorders, and diabesity.

39. THE NEWEST THERAPEUTICALLY APPROACH OF "DIABESITY" USING GLP-1 RA MOLECULES: IMPACT OF THE ORAL FORMULATION.

40. Prevalence of and Risk Factors for Diabesity in Urban Chennai.

41. Built environment correlates of diabetes and obesity: Methodology

42. Influence of Educational Level and Healthy Habits on the Prevalence of Diabesity in a Spanish Working Population.

43. Built Environment Correlates of Diabetes and Obesity: Methodology.

44. Reversal of Diabesity: Normalization of Insulin Release Curve in Association with Reversal of Non-Alcoholic Fatty Liver Disease.

45. PREVALENCE AND INFLUENCING FACTORS OF TYPE 2 DIABETES AMONG OBESE PATIENTS (DIABESITY) ATTENDING SELECTED HEALTHCARE FACILITIES IN CALABAR, NIGERIA: A MIXED METHOD STUDY

46. Morus alba : natural and valuable effects in weight loss management.

47. Reversal of Roux-en-Y Gastric Bypass to Normal Anatomy in a Severely Malnourished Patient After Metabolic Bariatric Surgery.

48. Semaglutide for the management of diabesity: The real-world experience.

49. Synthesis, molecular docking, and pharmacological evaluation of 5-(4-(2-(5-ethyl pyridine-2-yl) ethoxy) benzyl)-3-(phenylsulfonyl) thiazolidine-2, 4-dione against HFD-induced diabesity via interaction with the CB1 receptor.

50. Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators.

Catalog

Books, media, physical & digital resources